|
ARV-6723 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Arvinas Inc.1
Indications
- Liver Disease1
- Advanced Solid Tumor1
- Liver Cancer1
- Lung Cancer1
- Breast Cancer1
Huntersville, North Carolina1 trial
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Clinical Trial Site
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.